Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Emergency Service, Hospital | 20 | 2022 | 711 | 2.820 |
Why?
|
Meningitis, Bacterial | 10 | 2020 | 14 | 1.950 |
Why?
|
Cardiopulmonary Resuscitation | 3 | 2021 | 72 | 1.930 |
Why?
|
Bacteremia | 11 | 2020 | 155 | 1.820 |
Why?
|
Fever | 8 | 2022 | 96 | 1.380 |
Why?
|
Herpes Simplex | 5 | 2022 | 35 | 1.250 |
Why?
|
Out-of-Hospital Cardiac Arrest | 2 | 2020 | 11 | 1.250 |
Why?
|
Simplexvirus | 2 | 2022 | 26 | 0.980 |
Why?
|
Soft Tissue Infections | 2 | 2022 | 19 | 0.940 |
Why?
|
Infant | 24 | 2022 | 2891 | 0.920 |
Why?
|
Child | 15 | 2022 | 6405 | 0.860 |
Why?
|
Bacterial Infections | 5 | 2022 | 163 | 0.820 |
Why?
|
Heart Arrest | 2 | 2020 | 113 | 0.810 |
Why?
|
Hospitalization | 7 | 2022 | 978 | 0.810 |
Why?
|
Hospitals, Pediatric | 2 | 2021 | 114 | 0.790 |
Why?
|
Resuscitation | 1 | 2021 | 77 | 0.770 |
Why?
|
Emergency Medical Services | 2 | 2022 | 225 | 0.760 |
Why?
|
Point-of-Care Testing | 1 | 2020 | 12 | 0.740 |
Why?
|
Skin Diseases, Infectious | 1 | 2020 | 16 | 0.740 |
Why?
|
Lacerations | 1 | 2018 | 13 | 0.640 |
Why?
|
Ultrasonography | 1 | 2020 | 453 | 0.640 |
Why?
|
Spinal Puncture | 5 | 2020 | 38 | 0.630 |
Why?
|
Allied Health Personnel | 1 | 2018 | 37 | 0.630 |
Why?
|
Suture Techniques | 1 | 2018 | 75 | 0.630 |
Why?
|
Lidocaine | 1 | 2017 | 36 | 0.570 |
Why?
|
Premedication | 1 | 2017 | 49 | 0.560 |
Why?
|
Midazolam | 1 | 2017 | 46 | 0.560 |
Why?
|
Hypnotics and Sedatives | 1 | 2017 | 96 | 0.540 |
Why?
|
Anesthetics, Local | 1 | 2017 | 83 | 0.540 |
Why?
|
Humans | 42 | 2022 | 68618 | 0.520 |
Why?
|
Infant, Newborn | 16 | 2022 | 2455 | 0.520 |
Why?
|
Stress, Psychological | 2 | 2019 | 824 | 0.510 |
Why?
|
Emergency Medicine | 3 | 2022 | 88 | 0.490 |
Why?
|
Retrospective Studies | 19 | 2022 | 7277 | 0.470 |
Why?
|
Anti-Bacterial Agents | 6 | 2020 | 1026 | 0.470 |
Why?
|
Cross-Sectional Studies | 11 | 2021 | 2279 | 0.400 |
Why?
|
Pediatrics | 2 | 2015 | 341 | 0.390 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 2223 | 0.390 |
Why?
|
Otitis Media | 2 | 2022 | 35 | 0.390 |
Why?
|
Prospective Studies | 5 | 2022 | 3705 | 0.360 |
Why?
|
Emergencies | 1 | 2010 | 107 | 0.360 |
Why?
|
Interdisciplinary Communication | 1 | 2010 | 93 | 0.360 |
Why?
|
Safety Management | 1 | 2010 | 73 | 0.350 |
Why?
|
Male | 24 | 2021 | 37321 | 0.330 |
Why?
|
Leukocyte Count | 2 | 2020 | 94 | 0.320 |
Why?
|
Female | 24 | 2022 | 38074 | 0.320 |
Why?
|
Patient Care Team | 1 | 2010 | 311 | 0.320 |
Why?
|
Pain Measurement | 2 | 2021 | 328 | 0.310 |
Why?
|
Cohort Studies | 4 | 2022 | 2358 | 0.300 |
Why?
|
Child, Preschool | 5 | 2021 | 3187 | 0.290 |
Why?
|
Bicycling | 1 | 2007 | 39 | 0.280 |
Why?
|
Heart Injuries | 1 | 2007 | 25 | 0.280 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2007 | 59 | 0.280 |
Why?
|
Thoracic Injuries | 1 | 2007 | 44 | 0.280 |
Why?
|
Wounds, Nonpenetrating | 1 | 2007 | 131 | 0.260 |
Why?
|
Urinary Tract Infections | 3 | 2020 | 71 | 0.250 |
Why?
|
Odds Ratio | 3 | 2022 | 880 | 0.240 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2022 | 92 | 0.240 |
Why?
|
Staphylococcal Infections | 2 | 2022 | 156 | 0.230 |
Why?
|
Length of Stay | 3 | 2022 | 780 | 0.230 |
Why?
|
United States | 8 | 2022 | 7367 | 0.210 |
Why?
|
Pediatric Emergency Medicine | 1 | 2022 | 14 | 0.200 |
Why?
|
Chorioamnionitis | 1 | 2022 | 40 | 0.200 |
Why?
|
Mastitis | 1 | 2021 | 1 | 0.200 |
Why?
|
Heart Failure | 2 | 2022 | 1180 | 0.200 |
Why?
|
Infant, Newborn, Diseases | 1 | 2022 | 91 | 0.190 |
Why?
|
Triage | 1 | 2022 | 109 | 0.190 |
Why?
|
Risk Assessment | 4 | 2021 | 2007 | 0.190 |
Why?
|
Lymphadenitis | 1 | 2020 | 5 | 0.190 |
Why?
|
Interleukin-6 | 2 | 2019 | 330 | 0.190 |
Why?
|
Skin Diseases | 1 | 2022 | 122 | 0.180 |
Why?
|
Spectrum Analysis | 1 | 2020 | 81 | 0.180 |
Why?
|
Erythrocyte Count | 1 | 2020 | 14 | 0.180 |
Why?
|
Shiga-Toxigenic Escherichia coli | 1 | 2020 | 1 | 0.180 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2020 | 9 | 0.180 |
Why?
|
Cerebrospinal Fluid | 2 | 2018 | 23 | 0.180 |
Why?
|
Hypothermia | 1 | 2020 | 37 | 0.180 |
Why?
|
Escherichia coli Infections | 1 | 2020 | 47 | 0.180 |
Why?
|
Bacteriuria | 1 | 2019 | 7 | 0.170 |
Why?
|
Patient Transfer | 1 | 2020 | 86 | 0.170 |
Why?
|
Adolescent | 5 | 2022 | 8912 | 0.160 |
Why?
|
Infant Mortality | 1 | 2018 | 59 | 0.160 |
Why?
|
Physicians | 1 | 2022 | 324 | 0.160 |
Why?
|
Pain | 1 | 2021 | 472 | 0.150 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 2017 | 4 | 0.150 |
Why?
|
Meningitis | 1 | 2018 | 23 | 0.150 |
Why?
|
Near Drowning | 1 | 2017 | 3 | 0.150 |
Why?
|
Dementia | 1 | 2019 | 158 | 0.150 |
Why?
|
Blood Proteins | 1 | 2017 | 94 | 0.150 |
Why?
|
Administration, Topical | 1 | 2017 | 111 | 0.140 |
Why?
|
Administration, Intranasal | 1 | 2017 | 88 | 0.140 |
Why?
|
Bacteria | 1 | 2018 | 193 | 0.140 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 498 | 0.130 |
Why?
|
Caregivers | 1 | 2019 | 365 | 0.130 |
Why?
|
Psychometrics | 1 | 2018 | 514 | 0.130 |
Why?
|
Prognosis | 1 | 2020 | 2093 | 0.130 |
Why?
|
Patient Discharge | 1 | 2017 | 294 | 0.120 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 468 | 0.120 |
Why?
|
Anatomic Landmarks | 1 | 2015 | 8 | 0.120 |
Why?
|
Risk Factors | 3 | 2021 | 5731 | 0.120 |
Why?
|
Ultrasonography, Interventional | 1 | 2015 | 119 | 0.120 |
Why?
|
Aged | 4 | 2022 | 14862 | 0.110 |
Why?
|
Double-Blind Method | 1 | 2017 | 1738 | 0.110 |
Why?
|
Case-Control Studies | 3 | 2021 | 1553 | 0.100 |
Why?
|
Depression | 1 | 2019 | 943 | 0.100 |
Why?
|
Treatment Outcome | 2 | 2020 | 7029 | 0.100 |
Why?
|
Spain | 2 | 2021 | 34 | 0.100 |
Why?
|
Hospital Communication Systems | 1 | 2010 | 3 | 0.090 |
Why?
|
Patient Identification Systems | 1 | 2010 | 18 | 0.090 |
Why?
|
Aviation | 1 | 2010 | 13 | 0.090 |
Why?
|
Electronic Prescribing | 1 | 2010 | 9 | 0.090 |
Why?
|
Age Factors | 3 | 2021 | 1864 | 0.090 |
Why?
|
Emergency Medical Service Communication Systems | 1 | 2010 | 25 | 0.090 |
Why?
|
Social Responsibility | 1 | 2010 | 39 | 0.090 |
Why?
|
Echocardiography | 2 | 2019 | 515 | 0.090 |
Why?
|
Communication Barriers | 1 | 2010 | 48 | 0.090 |
Why?
|
Canada | 2 | 2021 | 267 | 0.090 |
Why?
|
Health Resources | 1 | 2010 | 76 | 0.090 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2022 | 101 | 0.090 |
Why?
|
Medical Errors | 1 | 2010 | 80 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 1085 | 0.090 |
Why?
|
Brain | 1 | 2020 | 2176 | 0.090 |
Why?
|
Young Adult | 1 | 2020 | 5717 | 0.080 |
Why?
|
Medication Errors | 1 | 2010 | 116 | 0.080 |
Why?
|
Leadership | 1 | 2010 | 136 | 0.080 |
Why?
|
Interprofessional Relations | 1 | 2010 | 188 | 0.080 |
Why?
|
ROC Curve | 2 | 2020 | 392 | 0.080 |
Why?
|
Follow-Up Studies | 3 | 2019 | 3259 | 0.080 |
Why?
|
Obesity | 1 | 2015 | 1076 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2010 | 374 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2019 | 626 | 0.070 |
Why?
|
Middle Aged | 2 | 2021 | 21147 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 1753 | 0.070 |
Why?
|
Comorbidity | 2 | 2021 | 1426 | 0.070 |
Why?
|
Pregnancy | 2 | 2022 | 2334 | 0.060 |
Why?
|
Biomarkers | 2 | 2022 | 1593 | 0.060 |
Why?
|
Incidence | 2 | 2018 | 1603 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2019 | 2077 | 0.060 |
Why?
|
Tympanic Membrane | 1 | 2022 | 25 | 0.050 |
Why?
|
Leukocytosis | 1 | 2021 | 13 | 0.050 |
Why?
|
Demography | 1 | 2022 | 279 | 0.050 |
Why?
|
Exanthema | 1 | 2021 | 30 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2022 | 180 | 0.050 |
Why?
|
Body Temperature | 1 | 2021 | 116 | 0.050 |
Why?
|
Eating | 1 | 2021 | 119 | 0.050 |
Why?
|
Urinalysis | 1 | 2020 | 27 | 0.050 |
Why?
|
Thrombocytopenia | 1 | 2021 | 122 | 0.050 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2021 | 113 | 0.050 |
Why?
|
Tertiary Care Centers | 1 | 2020 | 67 | 0.040 |
Why?
|
Drug Utilization | 1 | 2020 | 119 | 0.040 |
Why?
|
Staphylococcus aureus | 1 | 2021 | 175 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2020 | 40 | 0.040 |
Why?
|
Diarrhea | 1 | 2020 | 63 | 0.040 |
Why?
|
Injections, Intramuscular | 1 | 2019 | 44 | 0.040 |
Why?
|
Patient Admission | 1 | 2020 | 99 | 0.040 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 92 | 0.040 |
Why?
|
Infant, Premature | 1 | 2021 | 284 | 0.040 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 43 | 0.040 |
Why?
|
Propensity Score | 1 | 2019 | 117 | 0.040 |
Why?
|
Pneumonia | 1 | 2020 | 110 | 0.040 |
Why?
|
Seizures | 1 | 2021 | 279 | 0.040 |
Why?
|
Injections, Intravenous | 1 | 2019 | 215 | 0.040 |
Why?
|
Blood Culture | 1 | 2018 | 15 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2020 | 384 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2020 | 652 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 567 | 0.040 |
Why?
|
Cognition | 1 | 2022 | 513 | 0.040 |
Why?
|
Medical Records | 1 | 2018 | 121 | 0.040 |
Why?
|
Erythrocytes | 1 | 2017 | 137 | 0.040 |
Why?
|
Health Care Costs | 1 | 2020 | 346 | 0.040 |
Why?
|
Seasons | 1 | 2017 | 129 | 0.040 |
Why?
|
Area Under Curve | 1 | 2017 | 238 | 0.040 |
Why?
|
Prevalence | 1 | 2021 | 1619 | 0.040 |
Why?
|
Recurrence | 1 | 2019 | 948 | 0.030 |
Why?
|
Time-to-Treatment | 1 | 2017 | 117 | 0.030 |
Why?
|
Survival Rate | 1 | 2019 | 1056 | 0.030 |
Why?
|
Blood Glucose | 1 | 2019 | 631 | 0.030 |
Why?
|
Disease Progression | 1 | 2019 | 1038 | 0.030 |
Why?
|
Inflammation | 1 | 2022 | 1030 | 0.030 |
Why?
|
Chronic Disease | 1 | 2020 | 1330 | 0.030 |
Why?
|
Logistic Models | 1 | 2019 | 1420 | 0.030 |
Why?
|
Lumbosacral Region | 1 | 2015 | 18 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2020 | 1851 | 0.030 |
Why?
|
Manikins | 1 | 2015 | 42 | 0.030 |
Why?
|
Sex Factors | 1 | 2017 | 1266 | 0.030 |
Why?
|
Body Mass Index | 1 | 2015 | 867 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2019 | 4848 | 0.020 |
Why?
|
Time Factors | 1 | 2018 | 4655 | 0.020 |
Why?
|
Clinical Competence | 1 | 2015 | 657 | 0.020 |
Why?
|
Surveys and Questionnaires | 1 | 2015 | 2800 | 0.020 |
Why?
|